Pivotal Phase III study demonstrates substantial symptom relief in patients with systemic juvenile idiopathic arthritis treated with canakinumab

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:721 / 721
页数:1
相关论文
共 50 条
  • [31] MACROPHAGE ACTIVATION SYNDROME IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH TOCILIZUMAB
    De Benedetti, Fabrizio
    Schneider, Rayfel
    Weitzman, Sheila
    Devlin, Clare
    Daimaru, Kaori
    Yokota, Shumpei
    Takei, Syuji
    Ravelli, Angelo
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S5 - S5
  • [32] Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab
    Ravelli, Angelo
    Schneider, Rayfel
    Weitzman, Sheila
    Devlin, Clare
    Daimaru, Kaori
    Yokota, Shumpei
    Takei, Syuji
    De Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S83 - S84
  • [33] Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study
    Quartier, Pierre
    Alexeeva, Ekaterina
    Constantin, Tamas
    Chasnyk, Vyacheslav
    Wulffraat, Nico
    Palmblad, Karin
    Wouters, Carine
    Brunner, Hermine, I
    Marzan, Katherine
    Schneider, Rayfel
    Horneff, Gerd
    Martini, Alberto
    Anton, Jordi
    Wei, Xiaoling
    Slade, Alan
    Ruperto, Nicolino
    Abrams, Ken
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (02) : 336 - 346
  • [34] Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a phase III study
    N Ruperto
    H Brunner
    G Horneff
    P Quartier
    T Constantin
    Y Berkun
    M Erguven
    T Kallinich
    R Brik
    NM Wulffraat
    MA Ferrandiz
    L Rutkowska-Sak
    H Ozdogan
    L McCann
    K Lheritier
    R Preiss
    L Tseng
    A Martini
    DJ Lovell
    Pediatric Rheumatology, 9 (Suppl 1)
  • [35] Blueberry Improves the Therapeutic Effect of Etanercept on Patients with Juvenile Idiopathic Arthritis: Phase III Study
    Zhong, Yingjie
    Wang, Ye
    Guo, Jun
    Chu, Haifeng
    Gao, Yong
    Pang, Limin
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2015, 237 (03): : 183 - 191
  • [36] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A SINGLE-CENTER STUDY
    Alexeeva, E.
    Krekhova, E.
    Dvoryakovskaya, T.
    Isaeva, K.
    Chomakhidze, A.
    Chistyakova, E.
    Lomakina, O.
    Denisova, R.
    Mamutova, A.
    Fetisova, A.
    Gautier, M.
    Vankova, D.
    Shingarova, M.
    Kriulin, I.
    Alshevskaya, A.
    Moskalev, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1776 - 1777
  • [37] A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
    Ruperto, Nicolino
    Quartier, Pierre
    Wulffraat, Nico
    Woo, Patricia
    Ravelli, Angelo
    Mouy, Richard
    Bader-Meunier, Brigitte
    Vastert, Sebastiaan J.
    Noseda, Emanuele
    D'Ambrosio, Daniele
    Lecot, Jean
    Chakraborty, Abhijit
    Martini, Alberto
    Chioato, Andrea
    ARTHRITIS AND RHEUMATISM, 2012, 64 (02): : 557 - 567
  • [38] Single center study of Systemic Juvenile Idiopathic Arthritis in Moroccan patients
    Karima, Ghema
    Ghita, Benbrahim
    Hanane, Aboufaris
    Kenza, Sakhi Asmaa Bouayed
    RHEUMATOLOGY, 2023, 62
  • [39] SINGLE CENTER STUDY OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN MOROCCAN PATIENTS
    Karima, Ghema
    Ghita, Benbrahim
    Hanane, Aboufaris
    Kenza, Sakhi Asmaa Bouayed
    RHEUMATOLOGY, 2023, 62
  • [40] Phase III Study Results on the Efficacy and Safety of Canakinumab, a Long-Acting, Fully Human Anti-Interleukin-1β Antibody, in Systemic Juvenile Idiopathic Arthritis with Active Systemic Features.
    Brunner, Hermine
    Ruperto, Nicolino
    Horneff, Gerd
    Quartier, Pierre
    Constantin, Tamas
    Berkun, Yackov
    Kallinich, Tilmann
    Brik, Riva
    Ferrandiz, Manuel A.
    Lheritier, Karine
    Preiss, Ralph
    Tseng, Lillian
    Lovell, Daniel J.
    Martini, Alberto
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S1030 - S1030